Clinical Trial Update: DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hypoxia-profile-guided hypoxic modification of radiotherapy in head and neck squamous cell carcinoma; non-inferiority design.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Danish Head and Neck Cancer Group | Conditions: Head and Neck Squamous Cell Carcinoma, Radiotherapy | Phase 3 | Status: UNKNOWN